Cargando…

Macro-aspartate Aminotransferase: Misleading Finding in a Patient with Non-alcoholic Fatty Liver Disease

Persistent elevation of aspartate aminotransferase (AST) activity in serum due to the presence of a macro-enzyme form of AST (macro-AST) may lead to diagnostic confusion in many clinical conditions, particularly in those associated with chronic liver disease. We present a case of macro-AST in a pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Neha, Darr, Umar, Darr, Amir, Sood, Gagan K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716764/ https://www.ncbi.nlm.nih.gov/pubmed/31497458 http://dx.doi.org/10.7759/cureus.5042

Ejemplares similares

Stauffer Syndrome: A Comprehensive Review of the Icteric Variant of the Syndrome
por: Sharma, Neha, et al.
Publicado: (2019)

Bexarotene: A Rare Cause of Misleading Thyroid Function Tests
por: Pattan, Vishwanath, et al.
Publicado: (2020)

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2021)

How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
por: Odhaib, Samih A, et al.
Publicado: (2019)

Macro-Aspartate Aminotransferase: A Benign Cause of Abnormal Laboratory Findings
por: Reddy, Nikhil, et al.
Publicado: (2022)

Macro-aspartate aminotransferase in a healthy woman
por: Lorubbio, Maria, et al.
Publicado: (2020)

Importance Of Laboratory Detection Of Macro-Aspartate Aminotransferase
por: Ono, Shiro, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
por: Padda, Jaskamal, et al.
Publicado: (2021)

A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study
por: Wang, Min, et al.
Publicado: (2022)

Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review
por: Yaqub, Sayma, et al.
Publicado: (2021)

Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease
por: Mandal, Amrendra, et al.
Publicado: (2018)

Isolated elevated aspartate aminotransferase in an asymptomatic woman due to macro-aspartate aminotransferase: A case report
por: Zhan, Meng-Ru, et al.
Publicado: (2019)

Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease
por: Anekwe, Chika V, et al.
Publicado: (2020)

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease
por: Pokharel, Arbinda, et al.
Publicado: (2021)

The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
por: Venniyoor, Ajit, et al.
Publicado: (2021)

Advancements in Diagnostic and Therapeutic Interventions of Non-alcoholic Fatty Liver Disease: A Literature Review
por: Chaudhry, Ahtshamullah, et al.
Publicado: (2023)

Unraveling the Role of Hypothyroidism in Non-alcoholic Fatty Liver Disease Pathogenesis: Correlations, Conflicts, and the Current Stand
por: Gor, Rajvi, et al.
Publicado: (2021)

The Prospect of Non-Alcoholic Fatty Liver Disease in Adult Patients with Metabolic Syndrome: A Systematic Review
por: Zohara, Zareen, et al.
Publicado: (2023)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Autoimmune Hepatitis Refractory to Treatment Due to Underlying Grave’s Disease
por: Sawhney, Rahul, et al.
Publicado: (2019)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis (ANMDARE) in a Patient With Hashimoto’s Thyroiditis
por: Jain, Aakangsha, et al.
Publicado: (2022)

The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B.
Publicado: (2014)

Alanine aminotransferase to aspartate aminotransferase ratio and hepatitis B virus on metabolic syndrome: a community-based study
por: Lin, Ming-Shyan, et al.
Publicado: (2022)

Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan
por: Zahoor, Faizan, et al.
Publicado: (2023)

Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Edina, Brenda C, et al.
Publicado: (2022)

Distribution of serum concentrations reported for macroenzyme aspartate aminotransferase (macro-AST)
por: Rubin, Asa S., et al.
Publicado: (2017)

A Retrospective Study to Examine the Correlation of Bioelectrical Impedance Analysis with Shear-wave Elastography in Indian Patients with Non-alcoholic Fatty Liver Disease and Diabetes on Background Sodium-glucose Cotransporter-2 Inhibitor Therapy
por: Roy, Sayak, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know
por: Bikeyeva, Viktoriya, et al.
Publicado: (2022)

Nonlinear relationship between aspartate aminotransferase to alanine aminotransferase ratio and the risk of prediabetes: A retrospective study based on chinese adults
por: Cao, Changchun, et al.
Publicado: (2022)

The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Ndakotsu, Andrew, et al.
Publicado: (2022)

Aspartate Aminotransferase – Risk Marker for Type-2 Diabetes Mellitus or Red Herring?
por: Kunutsor, Setor K., et al.
Publicado: (2014)

Prevalence of Nonalcoholic Fatty Liver Disease at a Tertiary Care Center in Saudi Arabia
por: Hussein, Ghada, et al.
Publicado: (2023)

Macro-AST: misleading finding in an adolescent with MCAD-deficiency
por: Das, Anibh M, et al.
Publicado: (2012)

The Influence of Insulin Resistance on Outcomes in Hospitalizations for Alcohol-Related Liver Disease: A Nationwide Study
por: Okpujie, Victory, et al.
Publicado: (2023)

Effective Treatment of Nonalcoholic Fatty Liver Disease Using a Community-Based Weight Management Program
por: Hawa, Fadi, et al.
Publicado: (2021)

Effect of Dapagliflozin on Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Single-Center Survey
por: Das, Chandan, et al.
Publicado: (2021)

Aspartate aminotransferase/alanine aminotransferase ratio was associated with type 2 diabetic peripheral neuropathy in a Chinese population: A cross-sectional study
por: Yan, Pijun, et al.
Publicado: (2023)

An Observational Study of Reduction in Glycemic Parameters and Liver Stiffness by Saroglitazar 4 mg in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
por: Mitra, Asis
Publicado: (2020)

Does Type 2 Diabetes Increase the Risk of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Patients? A Systematic Review
por: Venugopal, Sathish, et al.
Publicado: (2023)

Primary Amenorrhea With Hypothyroidism: Finding the Cause
por: Alvi, Asim Munir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7bvifb10g2gr2043igh22jdaru